RecruitingPhase 4NCT06908252

MAPS PrEP Van Study

Integrating PrEP Into Mobile Addiction Treatment and Primary Care Services


Sponsor

Duke University

Enrollment

20 participants

Start Date

Sep 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing how well PrEP (a daily pill that prevents HIV infection) can be offered through a mobile van at a syringe services program, to make HIV prevention more accessible to people who inject drugs. **You may be eligible if...** - You are 18 or older - You are an active drug injection user and/or sexually active - You were referred from a Syringe Service Program **You may NOT be eligible if...** - You already have HIV Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPre-Exposure Prophylaxis (PrEP)

Oral Pre-Exposure Prophylaxis (PrEP) pills


Locations(1)

Duke Department of Population Health Sciences

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06908252


Related Trials